Genelux (GNLX) Price to Sales (2023 - 2024)
Genelux's (GNLX) Price to Sales stood at 20785.83 in FY2025, up 102.9% from 10244.80 in FY2024.
Powered by 
Analysis
Genelux (GNLX) Price to Sales (2023 - 2024) Analysis & Trends
- Per Business Quant data, GNLX's Price to Sales was 10244.80 in FY2024 (+364.0%) and 2207.73 in FY2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,230.11 Bn | 1,198.70 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 644.39 Bn | 564.25 Bn | 17.30 Bn |
| 3 | AbbVie | 503.52 Bn | 476.68 Bn | 12.70 Bn |
| 4 | Merck | 363.29 Bn | 317.72 Bn | 12.21 Bn |
| 5 | Novartis Ag | 298.23 Bn | 262.62 Bn | 11.24 Bn |
| 6 | Astrazeneca | 267.53 Bn | 241.29 Bn | 12.86 Bn |
| 7 | Amgen | 241.80 Bn | 197.20 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 195.07 Bn | 169.19 Bn | 6.22 Bn |
| 9 | Pfizer | 173.33 Bn | 120.28 Bn | 10.94 Bn |
| 10 | Genelux | 88.78 Mn | 27.06 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | 10,244.80 |
| Sep 30, 2024 | 10,231.94 |
| Jun 30, 2024 | 8,412.46 |
| Mar 31, 2024 | 21,698.63 |
| Dec 31, 2023 | 2,207.73 |
| Sep 30, 2023 | 2,743.08 |
| Jun 30, 2023 | 75.28 |
API Access
Genelux Price to Sales API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=price-to-sales&ticker=GNLX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "price-to-sales", "ticker": "GNLX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=price-to-sales&ticker=GNLX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();